Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous Mycobacterium species

Pediatric Infectious Disease Journal

Volumn 15, Issue 3, 1996, Pages 260-264

  Rodgers, Gail L ^a,c   Mortensen, Joel E ^a   Blecker Shelly, Deborah ^a   Fisher, Margaret C ^b   Long, Sarah S ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Nontuberculous mycobacteria

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; KANAMYCIN; SULFAFURAZOLE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIUM ISOLATION; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; CHILDHOOD CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SEPSIS;

ADOLESCENT; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; FATAL OUTCOME; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; OPPORTUNISTIC INFECTIONS; RHABDOMYOSARCOMA;

EID: 0029935358     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199603000-00016     Document Type: Review

References (50)

1. Hoy JF, Rolston KV, Hopfer KL et al. Mycobacterium fortuitum bacteremia in patients with cancer and long term venous catheters. Am J Med 1987;83:213-6.
2. Raad II, Vartivarian S, Khan A, et al. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13:1120-5.
3. Ausina V, Gurgui M, Verger G, et al. Iatrogenic disseminated Mycobacterium chelonei infection. Tubercle 1984;65:53-7.
4. Svirbely JR, Buesching WJ, Ayers LW, et al. Mycobacterium fortuitum infection of a Hickman catheter site. Am J Clin Pathol 1984;80:733-5.
5. Flynn PM, Van Hooser B, Gigliotti F.7 Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr Infect Dis J 1988;7:510-3.
6. Engler HD, Hass A, Hodes DS, et al. Mycobacterium chelonei infection of a Broviac catheter insertion site. Eur J Clin Microbiol Infect Dis 1989;8:521-3.
7. Speert DP, Munson D, Mitchell C, et al. Mycobacterium chelonei septicemia in a premature infant. J Pediatr 1980;96: 681-3.
8. Brady MT, Marcon MJ, Maddux H. Broviac catheter-related infection due to Mycobacterium fortuitum in a patient with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1987;6:492-4.
9. Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.
10. Newtown JA, Weiss PJ, Bowler WA, et al. Soft-tissue infection due to Mycobacterium smegmatis: report of two cases. Clin Infect Dis 1993;16:531-3.
11. Brown TH. The rapidly growing mycobacteria: Mycobacterium fortuitum and Mycobacterium chelonei. Infect Control 1985;6:283-8.
12. Edwards LB, Palmer CE. Isolation of "atypical" mycobacterial from healthy persons. Am Rev Respir Dis 1959;80:747-9.
13. Vance D. Mycobacterium chelonei sternal infection. Clin Microbiol Newslettz 1983;5:6.
14. Moerman J, Vandepitte J, Corbeel L, et al. Iatrogenic infections caused by the Mycobacterium fortuitum-chelonei complex. Acta Clin Belg 1985;40:92-8.
15. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacteruim fortuitum complex isolates. J Clin Microbiol 1981;14:686-91.
16. Butler WR, Kilburn JO. High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum and Mycobacterium smegmatis. J Clin Microbiol 1990;28:2094-8.
17. Friedmann FF. Der Schildkröten Tuberkelbazillus, seine Zuchtung, Biologie und Pathogenität. Zentralbl Bakteriol [A] 1903;34:647-62.
18. Moore M, Frerichs JB. An unusual acid fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region: report of a case with a study of the organism, Mycobacterium abscessus. J Invest Dermatol 1953;20:133-69.
19. daCosta Cruz J. Mycobacterium fortuitum: um novo bacilo acido-resistente patogenico para o homen. Acta Med Rio de Janiero 1938;1:297-301.
20. Ophüls W. Chronic subcutaneous abscess in man containing acid-proof bacilli in pure culture. J Med Res 1904;11:439-43.
21. Righter J, Hart GD, Howes M. Mycobacterium chelonei: report of a case of septicemia and review of the literature. Diagn Microbiol Infect Dis 1983;1:323-9.
22. Morris JT, Longfield RN. Disseminated infection due to Mycobacterium chelonei. South Med J 1992;85:1138-9.
23. Hamrick HJ, Maddux DW, Lowry EK, et al. Mycobacterium chelonei facial abscess: case presentation and review of cutaneous infection due to Runyon group IV organisms. Pediatr Infect Dis J 1984;3:335-40.
24. Paul J, Baigrie C, Parums DV. Fatal Case of disseminated infection with the turtle bacillus Mycobacterium chelonae. J Clin Pathol 1992;45.
25. LeBar WD, Ginnebaugh LA. Pericarditis caused by Mycobacterium chelonei. Clin Microbiol Newslett 1984;6:104.
26. Band JD, Ward JI, Fraser DW, et al. Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982;145: 9-17.
27. Smith RE, Salz JJ, Moors R, et al. Mycobacterium chelonei and orbital granuloma after tear duct probing. Am J Ophthalmol 1980;89:139-41.
28. Jauregui L, Arbulu A, Wilson F. Osteomyelitis, pericarditis, mediastinitis and vasculitis due to Mycobacterium chelonei. Am Rev Respir Dis 1977;115:699-703.
29. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59.
30. Borghans JGA, Stanford JL. Mycobacterium chelonei in abscesses after injection fof diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973;107:1-8.
31. Laskowski LF, Marr JJ, Spernoga JF, et al. Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N Engl J Med 1977;297:101-2.
32. Rumisek JD, Albus RA, Clarke JS. Late Mycobacterium chelonei bioprosthetic valve endocarditis: activation of implanted contaminant? Ann Thorac Surg 1985;39:277-9.
33. Foz A, Roy G, Jurado J, et al. Mycobacterium chelonei iatrogenic infections. J Clin Microbiol 1987;7:319-21.
34. Nontuberculous mycobacterial infections in hemodialysis patients: Louisiana, 1982. MMWR 1983;32:244-6.
35. Safranek TJ, Jarvis WR, Carson LA et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317:197-201.
36. Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;159: 708-16.
37. Huffman PC, Fraser DW, Robicsek F, et al. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981;143:533-42.
38. Robicsek F, Daugherty HK, Cook JW, et al. Mycobacterium fortuitum epidemics after open-heart surgery. J Thorac Cardiovasc Surg 1978;75:91-6.
39. Clegg HW, Foster MT, Sanders WE, et al. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammoplasty: clinical and epidemiologic features. J Infect Dis 1983;147:427-33.
40. Nolan CM, Hashisaki PA, Dundas DF. An outbreak of soft tissue infections due to Mycobacterium fortuitum associated with electromyography. J Infect Dis 1991;163:1150-3.
41. McWhinney PHM, Yates M, Prentice HG, et al. Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. Clin Infect Dis 1992;14:1208-12.
42. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976;136:67-70.
43. Ingram CW, Tanner DC, Durack DT, et al. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-71.
44. Wallace RJ Jr. The clinical presentation, diagnosis and therapy of cutaneous and pulmonary infections due to the rapid growing mycobacteria, M. fortuitum and M. chelonae. Clih Chest Med 1989;10:419-29.
45. Brown BA, Wallace RJ Jr, Onyi GO, et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-4.
46. Lederer J, Warner W, Leggiadro RJ. Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. Pediatr Infect Dis J 1993;12:697-8.
47. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections and resistance oral antimicrobials other than clarithromycin. J Infect Dis 1992;166:405-12.
48. Wallace RJ Jr, Tanner D, Brennan PJ, et al. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med,1993;119:482-6.
49. Wallace RJ Jr, Swenson JM, Silcox Va, et al. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J. Infect Dis 1985;152:500-14.
50. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991;35:773-5.